Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Irene J, Virgolini"'
Autor:
Leonhard Gruber, Clemens Decristoforo, Christian Uprimny, Peter Hohenberger, Stefan O. Schoenberg, Francesca Orlandi, Maurizio Franco Mariani, Claudia Manzl, Maria Theresia Kasseroler, Herbert Tilg, Bettina Zelger, Werner R. Jaschke, Irene J. Virgolini
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2899 (2022)
Background: Gastrin-releasing peptide receptors (GRPRs) are molecular imaging targets in multiple malignancies. Recently, NeoBOMB1, a 68Ga-labelled antagonist to GRPRs, was developed for PET. Here we report the outcome of a Phase I/IIa clinical trial
Externí odkaz:
https://doaj.org/article/63c13ec98b83463f9e24125f41e35422
Autor:
Anton A. Hörmann, Maximilian Klingler, Christine Rangger, Christian Mair, Clemens Decristoforo, Christian Uprimny, Irene J. Virgolini, Elisabeth von Guggenberg
Publikováno v:
Pharmaceuticals, Vol 14, Iss 6, p 575 (2021)
The new minigastrin analog DOTA-MGS5 is a promising new candidate for targeting cholecystokinin-2 receptor (CCK2R)-expressing tumors. To enable the clinical translation of PET/CT imaging using 68Ga-labeled DOTA-MGS5, different quality and safety aspe
Externí odkaz:
https://doaj.org/article/4c41814db8d44ae7ac2cda8bb2f878c5
Autor:
Elisabeth von Guggenberg, Christian Uprimny, Maximilian Klingler, Boris Warwitz, Anna Sviridenko, Steffen Bayerschmidt, Gianpaolo Di Santo, Irene J. Virgolini
Publikováno v:
Journal of Nuclear Medicine. :jnumed.122.264977
Autor:
Christian, Mair, Boris, Warwitz, Katharina, Fink, Lorenza, Scarpa, Bernhard, Nilica, Johanna, Maffey-Steffan, Sabine, Buxbaum, Irene J, Virgolini
Publikováno v:
Annals of nuclear medicine. 32(7)
As radionuclide therapy is gaining importance in palliative treatment of patients suffering from neuroendocrine tumour (NET) as well as castration resistant prostate cancer (CRPC), the radiation protection of patients, staff, family members and the g
Autor:
Christine, Rangger, Anna, Helbok, Meltem, Ocak, Thorsten, Radolf, Fritz, Andreae, Irene J, Virgolini, Elisabeth, Von Guggenberg, Clemens, Decristoforo
Publikováno v:
Anticancer research. 33(4)
Vasoactive intestinal peptide (VIP) receptors are overexpressed in a broad variety of tumours. For the detection of these tumours, novel chemically modified and shortened VIP derivatives were designed.1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacet
Autor:
Volker H, Schartinger, József, Dudás, Clemens, Decristoforo, Christoph, Url, Johannes, Schnabl, Georg, Göbel, Irene J, Virgolini, Herbert, Riechelmann, Michael, Rasse, Dietmar, Waitz, Daniel, Putzer
Publikováno v:
European journal of nuclear medicine and molecular imaging. 40(9)
⁶⁸Ga-labelled DOTA⁰-Tyr³-octreotide positron emission tomography (PET)/CT (⁶⁸Ga-DOTATOC PET/CT) is a routinely used imaging modality for neuroendocrine tumours expressing somatostatin receptors (SSTRs). Recent studies have shown that SSTRs
Autor:
Roland, Haubner, David R, Vera, Salman, Farshchi-Heydari, Anna, Helbok, Christine, Rangger, Daniel, Putzer, Irene J, Virgolini
Publikováno v:
European journal of nuclear medicine and molecular imaging. 40(8)
The hepatic asialoglycoprotein receptor is responsible for degradation of desialylated glycoproteins through receptor-mediated endocytosis. It has been shown that imaging of the receptor density using [(99m)Tc]diethylenetriamine pentaacetic acid (DTP